[Federal Register Volume 69, Number 137 (Monday, July 19, 2004)]
[Notices]
[Page 42989]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-16269]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Intent to Grant Exclusive Patent License; American
BioHealth Group, LLC
AGENCY: Department of the Navy, DOD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of the Navy hereby gives notice of its intent
to grant to American BioHealth Group, LLC, a revocable, nonassignable,
exclusive license to practice worldwide the Government-Owned inventions
described in U.S. Patent No. 6,649,621, issued 18 November 2003
entitled, ``Prevention or Reversal of Sensorineural Hearing Loss (SNHL)
Through Biological Mechanisms'' in the field of prevention and
treatment of noise-induced sensorineural inner ear damage by
administering either a nutraceutical or a pharmaceutically effective
amount of antioxidant compounds through various methods to include, but
not limited to, tablets, capsules, topical delivery vehicles and
sterile IV administered products.
DATES: Anyone wishing to object to the granting of this license has
fifteen (15) days from the date of this notice to file written
objections along with supporting evidence, if any.
ADDRESSES: Submit written objections to the Office of Technology
Transfer, Naval Medical Research Center, 503 Robert Grant Ave, Silver
Spring, MD 20910-7500.
FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant
Ave, Silver Spring, MD 20910-7500, telephone (301) 319-7428 or e-mail
at: [email protected].
Dated: July 8, 2004.
J. H. Wagshul,
Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register
Liaison Officer.
[FR Doc. 04-16269 Filed 7-16-04; 8:45 am]
BILLING CODE 3810-FF-P